Overview
Pseudomitragynine is a minor alkaloid found naturally in kratom leaves in very small quantities. It has gained market attention as some vendors began isolating and concentrating it for extract products, partly in response to regulatory pressure on 7-OH. The research base for pseudomitragynine is significantly smaller than for mitragynine or 7-OH.
How it works
Limited pharmacological data is available. Pseudomitragynine appears to interact with opioid receptors but its binding profile, potency relative to other alkaloids, and full mechanism of action are not well-characterized in published literature. Most of what's currently "known" comes from vendor claims and user reports rather than controlled studies.
Why it's on the market
As states have moved to ban or restrict 7-OH specifically, some manufacturers have pivoted to pseudomitragynine-based extracts as a legal alternative. This pattern of regulatory arbitrage is common in the kratom space and has also produced compounds like MGM-15.
Risk factors
The biggest risk factor with pseudomitragynine is the lack of data. With MIT and 7-OH, there's at least some published research on pharmacology and safety. With pseudo, you're largely in uncharted territory. Label accuracy is an even bigger concern here since standardized testing methods are less established.
Harm reduction
Apply extra caution with pseudo products. Start lower than you would with a known compound. Demand a COA. If the vendor can't provide one, walk away. Track your intake carefully and pay attention to how your tolerance changes over time.